The Structure of ¥48 Trillion in Medical Expenses — A Turning Point for Sustainability Toward 2030
Japan's medical expenses hit ¥48.09 trillion in FY2023—a record high. As spending grows relentlessly, the healthcare system faces sustainability challenges.
What's Happening
Japan's national medical expenses reached ¥48.0915 trillion in FY2023, an increase of ¥1.3948 trillion (+3.0%) from the previous year, setting a new record. Per capita, this amounts to ¥386,700—with lifetime medical expenses estimated at approximately ¥27.55 million from birth to death.
When placed in international comparison, Japan's position becomes clear. At 10.6% of GDP by OECD standards, this exceeds the OECD average of 9.3%. However, considering Japan's world-highest aging rate (29.3%), this is relatively well-controlled compared to the US at 16.7% and Germany at 12.7%.
The question is how long this "relative restraint" can be maintained.
Government projections from 2018 estimated medical benefit costs for FY2040 at ¥66.7-68.5 trillion (8.4-8.7% of GDP). However, the FY2023 actual figure of ¥48.0 trillion has nearly reached the same projections' FY2025 outlook (¥47.4-47.8 trillion). Medical expenses are expanding at a pace exceeding projections.
The structural drivers of increase are fourfold: demand growth due to aging, advancement of medical technology (insurance coverage of expensive new drugs and gene therapies), rising pharmaceutical costs (increasing at an average annual pace of approximately ¥780 billion), and chronic management costs for lifestyle diseases. None of these are factors likely to reverse in the short term.
Background and Context
The "Blueprint" of Funding Structure
Who bears the burden of ¥48 trillion in national medical expenses? Examining this breakdown reveals both the design philosophy and limitations of the system.
Late-Elderly Healthcare System Financing
Insurance premiums account for 48.8%, public funds (taxes) 38.9%, and patient out-of-pocket payments 11.6%. This "5:4:1" ratio forms the backbone of Japan's universal health insurance system. Since the system's creation in 1961, a framework ensuring all citizens belong to some form of public medical insurance has been maintained.
However, serious distortions have emerged within this funding structure. Looking at the Late-Stage Elderly Medical Care System (covering those 75 and older)—50% public funds, approximately 40% support payments from the working generation, and only 10% premiums from the elderly themselves. In other words, about 40% of the ¥17.3367 trillion in medical expenses for late-stage elderly is covered by "support payments" contributed by the working generation.
An even more shocking figure exists: the Late-Stage Elderly Medical Care System's reserves total ¥336.9 billion, covering only 0.23 months of benefit payments. There is virtually no financial buffer. Any unexpected increase in medical expenses would immediately require premium increases or public fund injection. This can only be described as operating on a tightrope.
Chain of Reforms—How High Will Patient Burden Rise?
To ensure system sustainability, reforms have been proceeding rapidly since 2024.
Review of the High-Cost Medical Expense System. A uniform 7% increase in limits across all income brackets in August 2026, followed by subdivision from 4 to 13 income categories with 7-38% increases in August 2027. Despite strong opposition from cancer patient groups leading to temporary suspension, a revised plan was decided in December 2025. The government estimates a medical expense suppression effect of approximately ¥107 billion.
Review of Insurance Benefits for OTC-Equivalent Drugs. For medications replaceable by over-the-counter drugs such as cold medicine, gastrointestinal drugs, and patches (approximately ¥1 trillion scale), a system requiring special patient payments while maintaining insurance benefits is under consideration, targeting implementation in March 2027.
"Ability-Based" Window Payment System. Discussion is underway to shift from age-based out-of-pocket payment ratios to "ability to pay" based on financial assets including financial income. There are moves toward legislation in the 2026 regular Diet session to include financial income in insurance premium and window payment determinations.
The common direction of these reforms is clear—a shift in burden principles from "age to ability." However, how will this balance the risk that increased burden may induce patients to avoid medical care, leading to disease severity? The precision of that system design is what's being questioned.
1.44-Fold Regional Disparity
Highest (high cost)
Lowest (low cost)
Per capita national medical expenses range from ¥496,300 in Kochi Prefecture to ¥342,500 in Saitama Prefecture—a 1.44-fold difference. This "high west, low east" structural pattern continues, deeply linked to uneven distribution of hospital beds and physicians.
The physician distribution index shows approximately 2-fold disparities at the prefectural level, with even larger gaps at the secondary medical care area level. Approximately 600 areas nationwide lack physicians, with about 2,000 locations taking over an hour to reach the nearest medical facility. The Ministry of Health, Labour and Welfare announced a "Physician Distribution Countermeasure Package" in December 2024, but its effectiveness remains to be tested.
Reading the Structure
The ¥48 trillion figure in national medical expenses represents not individual policy issues, but a structural turning point facing Japan's social security system.
The First Structure—"Accumulated Postponement". The fact that the 2025 level assumed in 2018 projections was nearly reached by 2023 means that medical expense containment measures are not functioning as expected. Biennial revisions of medical fees and drug price reductions—these measures can slow the "speed" of increase but lack the power to change "direction."
The Second Structure—"Intergenerational Asymmetry". The structure where 40% of late-stage elderly medical funding comes from working generation support payments becomes more unstable as population composition changes. The 2025 problem (all baby boomers reaching 75+) is merely the "beginning." The true burden will arrive from the late 2030s through the 2040s.
The Third Structure—"Spatial Fragmentation". The 1.44-fold disparity in medical expenses is not merely regional difference. There's a mechanism where uneven distribution of medical supply systems (hospital beds and physicians) induces demand, manifesting as medical expense differences. The classical proposition from health economics that supply creates demand is vividly reflected in Japan's prefectural data.
These three structures are not independent but mutually reinforcing. Postponement expands intergenerational burden, regional disparities make consensus-building for system reform difficult, and delayed consensus-building leads to further postponement.
2030 is not "still far away." It's a grace period for structurally reconsidering system design. Without analytical approaches that verify policy effects through EBPM methods and visualize intervention pathways through Logic Models, we cannot address the ¥48 trillion figure.
- Introduction to EBPM — What is Evidence-Based Policy Making?
- Logic Model Practical Guide — Visualizing Project Design
References
令和5年度 国民医療費の概況
厚生労働省. 厚生労働省
Read source
2040年を見据えた社会保障の将来見通し
内閣官房・内閣府・財務省・厚生労働省. 厚生労働省
Read source
Health at a Glance 2025 — Japan
OECD. OECD
Read source
高額療養費制度の見直しについて
厚生労働省 保険局. 厚生労働省
Read source
後期高齢者医療制度の積立金は医療費の0.23か月分
GemMed編集部. GemMed
Read source
